LUMEN Materna Clinical Overview

Pregnancy-Specific Nervous System Support Technology

Quick Facts

Target Population:Pregnant individuals, weeks 1-40
Classification:Investigational wellness device
Technology:HRV biofeedback, PEMF, haptic
Clinical Focus:Prenatal stress reduction
Development Phase:Pre-prototype
Request Full Technical Documentation
LUMEN Materna trimester progression - SPARK, DEEPENING, and PORTAL devices

Technical Platform

SPARK (Tri 1)
Acupressure + PEMF
DEEPENING (Tri 2)
HRV + Fetal Movement
PORTAL (Tri 3)
TENS + Labor Support
Safety
FDA Guidelines

Market Gap Analysis

Underserved Population

Despite pregnancy representing one of the most significant nervous system transformations in human physiology, no wearable biofeedback device has been designed specifically for maternal use. Existing devices (Apollo Neuro, Muse, etc.) serve general adult populations and lack pregnancy-specific calibrations.

Clinical Need

1 in 5

Pregnant individuals experience prenatal stress

Rising

Prenatal anxiety linked to adverse birth outcomes

Growing

Non-pharmaceutical interventions increasingly sought

Provider

Demand for objective prenatal stress monitoring

Current Limitations

Available solutions include:

  • Generic stress-reduction apps: No biofeedback, no physiological adaptation
  • Adapted adult wearables: Not calibrated for maternal physiology
  • Clinical-only monitoring: Expensive, not accessible for home use

LUMEN Materna addresses these limitations with pregnancy-specific technology.

Trimester-Specific Technology

Three distinct devices designed for the unique physiological needs of each trimester

SPARK: First Trimester Stabilization

Weeks 1-13 • Addressing early pregnancy challenges

LUMEN Materna SPARK - First trimester wearable device with P6 acupressure targeting

Target Symptoms

  • Nausea/hyperemesis support (P6 acupressure)
  • Hormonal adaptation stress
  • Early pregnancy anxiety
  • Temperature dysregulation

Technology Platform

Acupressure-Informed Stimulation
P6 (Nei Guan) point targeting for nausea relief
Gentle Vibration
10-40 Hz transcutaneous stimulation
Low-Frequency PEMF
1-10 Hz, <1 Gauss output
Temperature Monitoring
Passive tracking, no active output

Physiological Rationale

P6 (Nei Guan) acupressure point stimulation has demonstrated efficacy in nausea reduction in multiple clinical studies. Combined with low-frequency PEMF shown to support autonomic balance, SPARK addresses first trimester's unique challenges with evidence-based, non-pharmaceutical interventions.

Safety Profile

  • No electromagnetic exposure above background levels
  • PEMF levels 10x below FDA safety guidelines
  • Medical-grade biocompatible materials
  • Appropriate for early pregnancy use

Safety Profile & Regulatory Pathway

Electromagnetic Safety

PEMF Levels
<1 Gauss (FDA guideline: 10 Gauss)
Frequency Ranges
0.1-40 Hz (ELF spectrum)
RF Emissions
Bluetooth optional (not required)
EMC Standards
IEC 60601-1-2 (target)

Material Safety

  • Medical-grade silicone - ISO 10993 biocompatibility
  • Hypoallergenic metals - Copper, rose gold, platinum coatings
  • No latex, phthalates, or BPA - Pregnancy-safe materials only

Clinical Contraindications (Proposed)

  • Pacemaker/ICD users (PEMF interaction risk)
  • High-risk pregnancy (provider approval required)
  • Placental complications (provider consultation)
  • Multiple gestations (requires additional research)

Regulatory Pathway

LUMEN SoulTech is evaluating regulatory classification:

Option 1: General wellness device

Lowest regulatory burden

Option 2: 510(k) Class II medical device

Moderate evidence burden

Option 3: De novo classification

Novel technology pathway

We are consulting with FDA regulatory experts and OB/GYN clinical advisors to determine the most appropriate pathway that ensures safety while maintaining accessibility.

Partner With LUMEN: Research Opportunities

Building the evidence base through collaborative clinical research

Academic Partnerships

We Seek Collaborations With:

  • • University hospitals & academic medical centers
  • • Maternal-fetal medicine departments
  • • Midwifery and birthing center networks
  • • Nursing schools (perinatal specialization)
  • • Psychology departments (prenatal stress research)

Research Questions to Explore:

  • • Does trimester-specific HRV biofeedback reduce prenatal anxiety?
  • • Can fetal movement feedback enhance maternal-fetal attachment?
  • • Does intrapartum TENS + breathing reduce pain medication use?
  • • Optimal PEMF frequency for first-trimester nausea?
  • • Does prenatal training improve postpartum outcomes?

What We Provide:

  • Pre-prototype devices for research use
  • Technical support and training
  • Data analysis collaboration
  • Co-authorship on publications
  • Grant application support

Clinical Partnerships

We Seek Partnerships With:

  • • OB/GYN practices (private and hospital-based)
  • • Midwifery practices and birthing centers
  • • Maternal health clinics
  • • Perinatal mental health providers
  • • Lactation consultants and postpartum doulas

Clinical Validation Pathways:

  • • Pilot usability studies
  • • Patient satisfaction surveys
  • • Comparative effectiveness trials
  • • Long-term outcome tracking (maternal and infant)

Provider Benefits:

  • Early access to innovative technology
  • Objective prenatal stress monitoring
  • Non-pharmaceutical intervention option
  • Potential reduced intervention rates
  • Enhanced patient engagement

Frequently Asked Questions

Healthcare Providers & Institutional Partners

Regulatory & Safety

Clinical Application

Research & Data

Technology & Evidence

Partnership & Access

Have Additional Questions? Contact Our Clinical Team

Contact Clinical Team

Provider & Researcher Updates

Quarterly Clinical Development Newsletter

Receive updates on:

  • Clinical validation study results
  • Research partnership opportunities
  • Regulatory pathway progress
  • Conference presentations and publications
  • Early access opportunities for providers

Healthcare Provider Resources

Downloadable materials for institutional review and patient education

Clinical Overview (PDF)

2-page professional summary for OB/GYN practices

Request Document

Patient Education Handout (PDF)

What is LUMEN Materna? - Waiting room ready

Request Document

Technical Specifications (PDF)

Detailed engineering and safety documentation

Request Document

Safety Profile & Contraindications

Clinical reference guide

Request Document

Research Proposal Template (DOCX)

Editable template for institutional partners

Request Document

IRB Protocol Template (DOCX)

Pilot study protocol with informed consent

Request Document

Contact for Institutional Inquiries

We welcome partnerships with healthcare providers, researchers, and academic institutions

Shannon Giles, Founder & CEO

[email protected]

(806) 575-9157 ext. 7230

LUMEN SoulTech is a Texas-based medical device company (HUB Certified, SAM.gov Registered) developing generational nervous system support technology. All products are investigational and not yet available for commercial sale.

    Sarah's Sigil - LUMEN SoulTech